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Edited by Beat ImhofAbstract CD45 transduces activation signals in inﬂammatory
cells. We investigate CD45 expression on pancreatic acinar cells
and examine its role in the inﬂammatory response which these
cells have also shown under certain circumstances. Similar
CD45 mRNA levels were found in acinar cells and leukocytes
(positive control). Flowcytometric and immunohistochemical
analysis showed a heterogeneous CD45 distribution on acinar
cells. Activation of acinar cells by incubation with pancreatitis-
associated ascitic ﬂuid as evidencied by TNF-Æalphaæ production
resulted in a decreased CD45 expression, suggesting that CD45
acts as a negative regulator of cytokine production. As a valida-
tion of this ﬁnding in vivo, a decrease in the acinar CD45 expres-
sion in parallel with an increased ability to produce TNF-Æalphaæ
was found in rats with acute pancreatitis. Our data show that
CD45 is constitutively expressed in acinar cells and suggest that
it plays an important role in negatively regulating cytokine
production.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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CD45, formerly called leukocyte-common antigen (L-CA),
is an abundant transmembrane glycoprotein expressed in all
nucleated hematopoietic cells [1]. It is identiﬁed as a leuko-
cyte-speciﬁc receptor-like protein tyrosine phosphatase (PTP)
which plays an important role in regulating immune responses
[2,3]. The use of monoclonal antibodies demonstrated that
CD45 is an essential protein in normal T and B lymphocyte
development and antigen-receptor signalling [4,5]. It is gener-
ally thought that CD45 couples Src family kinases in order
to maintain Src kinases in a dephosphorylated state. However,
the mechanisms of CD45 modulation of Src activity is complex
and it has been suggested that CD45 may function as both po-
sitive and negative regulator of kinase activity [3]. In fact, theAbbreviations: AP, acute pancreatitis; FACS, ﬂuorescence activated
cell sorter; FITC, ﬂuorescein isothiocyanate; FSC, forward scatter;
MAPK, mitogen-activated protein kinase; PAAF, pancreatitis-asso-
ciated ascitic ﬂuid; PE/Cy5, phycoerythrin/cyanine5; PTP, protein
tyrosine phosphatase
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doi:10.1016/j.febslet.2005.10.017precise role of CD45 in leukocyte signalling and the mecha-
nisms that regulate CD45 functions are still poorly under-
stood.
Recent reports highlight the ability of pancreatic acinar cells
to respond, produce and release cytokines [6–9]. On this basis,
the notion that pancreatic acinar cells can behave as ‘‘real’’
inﬂammatory cells is an emerging concept. As CD45 transdu-
ces in leukocytes the activation of signals involved in immune
response [10], our ﬁrst aim was to evaluate the CD45 expres-
sion on acinar cells, The assessment of its presence, led us to
wonder whether CD45 activity might be required by pancreatic
cells to regulate cytokine production as reported for typical
inﬂammatory cells [11,12]. In order to investigate this point,
simultaneous analysis of CD45 and TNF-Æalphaæ were per-
formed in activated acinar cells obtained in in vitro experi-
ments and in vivo from rats with acute pancreatitis (AP).2. Materials and methods
2.1. Animals
Male Wistar rats (250–300 g body weight) were used. Animals were
kept in a controlled environment with free access to water and stan-
dard laboratory chow (Panlab, Madrid, Spain). The experiments were
performed according to the protocols approved by the Institutional
Animal Care and Use Committee of the University of Salamanca
(Spain) in accordance with the guidelines of the European Community
Council Directive (86/609/EEC), and conformed to NIH guidelines.
2.2. Isolation of acinar cells
Under anaesthesia with sodium pentobarbital (30 mg/kg) blood
samples were ﬁrstly taken by cardiac puncture on heparinized tubes.
Afterwards, pancreata were dissected, placed on ice, freed from fat
and lymph nodes and immediately acinar cells were isolated by diges-
tion with collagenase as previously described [8]. In order to avoid the
RNA acinar cell degradation, the isolation procedure of acinar cells
used in RT-PCR analysis was carried out in an RNase-free environ-
ment and was shortened as follows: pancreata were digested by incuba-
tion with collagenase at 20 C for 8 min with vigorous shaking. After
two washes with PBS and following gentle pipetting through tips of
decreasing diameter (3–1 mm), cells were ﬁltered through a sterile dou-
ble layer of muslin gauze and centrifuged at 700 · g for 4 min at 4 C.
Then the cell pellet was resuspended in PBS and centrifuged twice at
500 · g for 3 min at 4 C. Cell viability was assessed by blue trypan
dye exclusion (>95%).
2.3. Reverse transcriptase-polymerase chain reaction (RT-PCR)
To detect CD45 mRNA, RT-PCR was performed on acinar cells
and leukocytes (positive control). Total RNA was extracted from the
cells using RNA easy kit treated with ampliﬁcation grade DNase 1blished by Elsevier B.V. All rights reserved.
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tions. Purity of RNA was veriﬁed by ethidium bromide staining on
1% agarose gels. cDNA synthesis was performed using combined Titan
One tube reaction kit (Roche Applied Science, Penzberg, Germany) in
the presence of 0.5 lg total RNA and 0.2 lM CD45 primers (sense:
5 0-CCGTTGTACACCAGAGATGA-3 0, antisense: 5 0-TCCCAAAA-
TCAGTCTGCAC-3 0, product size: 167 bp). Oligonucleotide primers
for b-actin (sense: 5 0-CACGGCATTGTAACCAACTG-30, antisense:
5 0-TCTCAGCTGTGGTGGTGAAG-30, product size: 400 bp) were
used as internal control. RT-PCR was performed following proce-
dures: 50 C for 30 min, 1 cycle, 94 C for 5 min, 1 cycle, 94 C for
30 s, 53 C for 30 s, 68 C for 45 s, 25 cycles, 68 C for 7 min, 1 cycle.
The ampliﬁed RT-PCR products were separated on a 2% agarose gel
stained with ethidium bromide and densitometrically quantiﬁed with
an Gel Doc 1000/2000 image analysis system (BioRad) using the Quan-
tityOne software programme. The CD45 and Æbetaæ-actin RT-PCR
products were run together on the same gel in order to normalize
the band densities to the Æbetaæ-actin band and the results were ex-
pressed as a ratio.
2.4. Flow cytometry analysis: phenotyping and sorting
CD45 expression in acinar cells was assessed through ﬂow cytomet-
ric analysis. Phenotypic analysis were carried out by double staining
using phycoerythrin/cyanine 5 (PE/Cy5)-labelled anti-rat CD45 mono-
clonal antiserum (clone number, OX-1, BD Pharmingen, San Diego,
CA, USA) and FITC-labelled anti-rat trypsinogen antiserum obtained
in our laboratory [13]. For this, 100 ll of acinar cells (106 cells) were
ﬁrstly incubated with CD45-PE/Cy5 at room temperature for 15 min.
Unbound antiserum was removed by washing twice in phosphate-buf-
fered saline (PBS, 0.1 M, pH 7.4) and then acinar cells were ﬁxed with
Fix solution (V:V) (Fix&Perm kit, Caltag Laboratories, San Francisco,
CA, USA) for 15 min. After washing with PBS, Perm solution was
added (V:V) together with FITC-anti-trypsinogen antiserum and the
mixture was incubated for 15 min at room temperature. The unbound
antiserum was removed by washing in PBS. All steps were carried out
in the dark. Analysis were performed on a FACScalibur ﬂow cytome-
ter (Becton Dickinson Biosciences, San Jose´, Ca, USA) equipped with
a doublet discrimination module. In each experiment at least 10000
cells were analysed. Data acquisition and analysis were performed
using the Cell Quest and Paint-a-Gate PRO software programs (Bec-
ton Dickinson), respectively. Acinar cells were gated according to their
forward scatter/trypsinogen distribution. Non-speciﬁc ﬂuorescence
was determined by isotype matched mouse IgG1Ækappaæ as control
antibody (Pharmingen). Dead cells showing very low forward scatter
were discarded.
To perform ﬂowcytometric sorting analysis, PE/Cy-CD45 labelled
acinar cells of control rats were gated out and fractioned into speciﬁc
cell populations (CD45+ and CD45) according to their relative
expression of CD45 using a FACSVantage ﬂow cytometer (Becton
Dickinson Biosciences) as previously described [14]. After sorting, po-
sitive and negative CD45 cell populations were cytocentrifuged (45 · g,
5 min) into glass slides, air dried, ﬁxed in methanol, and observed by
light microscopy.2.5. Immunohistochemistry
In situ CD45 distribution was examined in pancreas sections and
isolated acinar cells of control rats. In order to remove blood cells from
pancreatic tissue, animals were perfused, under anaesthesia, ﬁrst with
0.9% saline for one minute and then with buﬀered formalin. After-
wards, the pancreas was removed, ﬁxed and embedded in paraﬃn. 7-
lm sections were cut and mounted onto gelatin-coated slides. They
were deparaﬃned in xylene, hydrated in graded ethanol and then incu-
bated for 10 min in 2% H2O2 (v:v) in methanol in order to block
endogenous peroxidase activity. From this point, procedures were sim-
ilar for both sections and isolated cells (ﬁxed onto polylysine-coated
slides). After antigen retrieval by incubating at 90 C for 10 min with
BD Retrievagen A (BD Pharmingen), all specimens were sequentially
incubated in: (i) blocking solution containing 5% normal goat serum
(Sigma Chemical Co., Madrid, Spain) and 0.1% Triton X-100 in
0.1 M PBS for 1 h at room temperature; (ii) monoclonal mouse anti-
rat CD45 (BD Pharmingen) (1:10 dilution in PBS containing 5% nor-
mal goat serum, 0.1% Triton X-100) for 72 h at 4 C; (iii) Cyanine Cy3
AﬃniPure Goat anti-mouse IgG (Jackson Immunoresearch Laborato-
ries, West Grove, PA, USA) (1:500 dilution, in PBS containing 0.05%Triton X-100 and 5% normal goat serum, v:v) for 2 h at room temper-
ature and (iv) 4 0,6-diamidine-2-phenylindole (DAPI) counterstain
solution (Sigma), (1:10000 dilution, v:v) for 8 min at room tempera-
ture. After each step, the slides were carefully rinsed in PBS
(3 · 10 min). Finally, they were analyzed under a ﬂuorescence micro-
scope (Olympus Provis AX70). Control experiments by omitting the
primary or secondary antibody, or by incubating with puriﬁed mouse
IgG1Ækappaæ isotype control (BD Pharmingen) were performed.
2.6. CD45 expression in activated acinar cells
Acinar cells of control rats were activated in vitro by incubation with
pancreatitis-associated ascitic ﬂuid (PAAF) collected from rats with
AP induced by bile-pancreatic duct obstruction (BPDO) for 24 h,
which was reported to be able to induce TNF-Æalphaæ production in
acinar cells [7]. For this, immediately after isolating acinar cells were
resuspended in medium 199 (Gibco, Paisley, Scotlamd) supplemented
with 10% (v:v) heat-inactivated calf foetal serum (Biowhittaker, Walk-
ersville, MD, USA), streptomicyn (0.1 mg/ml) and penicillin (100 U/
ml) solution (Sigma) and plated at a density of 4 · 106/ml on 24-well
primary culture plates (Becton Dickinson Biosciences). After adding
10 lg/ml of Brefeldin A (Sigma) as a cytokine-secretion blocking agent,
acinar cells were incubated for 4 h in a 5% CO2 humidiﬁed, sterile
atmosphere at 37 C in absence or presence of PAAF. In the other
hand, experiments were carried out with acinar cells isolated from pan-
creas of rats with AP induced by BPDO for 12 h and the respective
sham operated rats. In presence of Brefeldin A but in absence of PAAF
they were cultured for 4 h as described above.
Immediately, acinar cells were double labelled with PE/Cy5-anti-
CD45 and PE-TNF-Æalphaæ (clone number TN3-19.12, BD Pharmin-
gen) antisera and analysed by ﬂow cytometry.
2.7. Statistical analysis
Results are means ± S.E.M. Students t test was used in the compar-
ison of data. P values lower than 0.05 were considered to be statisti-
cally signiﬁcant.3. Results
3.1. RT-PCR demonstration of CD45 expression on pancreatic
acinar cells
As Fig. 1 shows prominent CD45 RT-PCR products were
found in acinar cells. As a positive control we identiﬁed
CD45 mRNA in leukocytes. CD45/Æbetaæ-actin mRNA ratio
indicated similar levels of CD45 mRNA expression in acinar
cells and leukocytes.
3.2. Flow cytometric demonstration of CD45 expression on
pancreatic acinar cells
At the protein level, we analysed the CD45 expression on the
surface of acinar cells by ﬂow cytometry (Fig. 2). Only trypsin-
ogen positive cells were assessed as acinar cells and gated out
for the analysis of CD45 labelling. Fig. 2a shows a representa-
tive example of the ﬂow cytometric distribution of acinar cells
according to the ﬂuorescence (FL) due to anti-trypsinogen-
FITC (FL1) and to anti-CD45-PE/Cy5 (FL3) labelling. Immu-
nophenotypic characterization by ﬂow cytometry revealed a
constitutive expression of CD45 in almost 80% of total acinar
cells (Fig. 2b and c). After FACSsorting, CD45+ cells were
assessed by light microscopy as acinar cells (>99%) (data not
shown).3.3. Immunohistochemical demonstration of CD45 expression on
pancreatic acinar cells
To conﬁrm CD45 expression in pancreatic acinar cells,
immunohistochemical analysis was performed on pancreatic
tissue and isolated acinar cells. CD45 immunostaining of acinar
Fig. 1. Representative RT-PCR for the expression of CD45 and the
housekeeping gene Æbetaæ-actin in pancreatic acinar cells (lane 1) and
leukocytes (lane 2). Left lane shows DNA size markers. The results are
representative of 5 experiments performed on diﬀerent preparations of
cells. RT-PCR products were normalized to that of house keeping gene
Æbetaæ-actin in the same sample. Graph shows a summary of CD45
mRNA expression levels given as means ± S.E.M.
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isolated acinar cells (Fig. 3d and e). No expression of CD45
was found in nearly 25% of acinar cells and in those cells
positively stained diﬀerent levels of CD45 expression were
found. No staining for CD45 was found in isotype-matched
negative control (Fig. 3c) nor in controls performed by omitting
the primary or secondary antibody (data not shown).
3.4. Expression of CD45 and TNF-Æalphaæ in activated acinar
cells
Fig. 4 shows a representative example of the ﬂow cytometric
distribution of non-stimulated and 24 h-BPDO PAAF-stimu-
lated acinar cells according to the ﬂuorescence (FL) due to
anti-TNF-Æalphaæ-PE (FL2) and anti-CD45-PE/Cy5 (FL3)
labelling. An inverse correlation between CD45 expressionFig. 2. Immunophenotype of acinar cells by ﬂuorescence activated cell so
determine the expression of CD45 (FL3: red ﬂuorescence due to phycoeryt
(FL1: green ﬂuorescence due to ﬂuorescein isothiocianate (FITC) staining) (
relative distribution of CD45 labelling. One representative experiment of 10
pancreatic acinar cells expressing CD45 (CD45+ cells).and TNF-a production can be observed in activated cells.
According to the mean value of ﬂuorescence intensity, acinar
cells of control rats signiﬁcantly (P < 0.01) increased the
TNF-[alpha] production and signiﬁcantly (P < 0.05) decreased
CD45 expression in response to PAAF.
Likewise, acinar cells activated in vivo after inducing AP by
BPDO showed a signiﬁcant decrease in CD45 expression as
analysed by either RT-PCR (Fig. 5) and ﬂow cytometry
(Fig. 6) in parallel with a signiﬁcant (P < 0.05) increase in
TNF-Æalphaæ production.4. Discussion
To the best of our knowledge, this study provides the ﬁrst
evidence that pancreatic acinar cells express CD45. Interest-
ingly, a selective CD45 labelling of acinar cells was found by
ﬂow cytometry, a result conﬁrmed by immunohistochemical
studies, in which a non-uniform staining was observed both
in pancreatic tissue sections and isolated acinar cells. MoAbs
are considered to be targeted to a single epitope only, therefore
the presence of CD45 on pancreatic acinar cells would clearly
seem to be evident. This notion is supported by the expression
of CD45 mRNA found at similar levels to leukocytes. This
ﬁnding turned out quite unexpected and may become a revolu-
tionary concept on the basis that CD45 has been traditionally
considered to be expressed exclusively in hematopoietic cells,
except mature erythrocytes and platelets [1]. On this basis,
MoAbs against CD45 have been widely developed and are
commercially available from diﬀerent companies for labelling
and speciﬁc identiﬁcation of hematopoietic cells by diﬀerent
techniques. CD45 has also been detected in murine microglia
[15] a ﬁnding that is to be expected, considering that microglial
cells are the main immune eﬀector element in the central ner-
vous system [16].
The results shown in the present study strongly support the
notion that the acinar cell may function as an immunocompe-
tent cell. Although the main function of pancreatic acinar cells
is the secretion of digestive enzymes into the duodenum, they
have also been shown to be capable of mounting an inﬂamma-
tory response. Diﬀerent reports have demonstrated that acinar
cells are important components for initiating inﬂammatoryrter (FACS) analysis. Two color FACS analysis was performed to
hrin/cyanine 5 (PE/Cy5) labelling) in trypsinogen labelled acinar cells
panel a). Histogram b shows Fl3-negative control (light grey) and the
is shown. Graph c shows mean values ± S.E.M. of the percentage of
Fig. 3. Immunohistochemical analysis for CD45 expression on pan-
creatic acinar cells. (a) Pancreatic tissue sections stained with hema-
toxylin-eosin. (b) CD45 immunostaining (red) of the same pancreatic
sections as in (a) counterstained with 4 0,6-diamidine-2-phenylindole
(DAPI) to identify nuclei (blue). Diﬀerent levels of CD45 expression
were observed in the positively stained acinar cells. (c) Isotype-matched
negative controls. No CD45 staining was found. (d) High magniﬁca-
tion of one pancreatic acinus exhibiting diﬀerent levels of CD45
expression. (e) CD45 immunostaining of isolated acinar cells. Only
some of them were immunopositive, showing diﬀerent levels of CD45
expression. Scale bar 25 lm (a–c) and 10 lm (d,e).
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play a pivotal role in the pancreatic inﬂammatory response
triggered oﬀ as a result of the enzymatic injury by producingcytokines and chemokines [6–8,17,18]. In addition, pancreatic
acinar cells have been shown to be capable of responding to
cytokines [6,19], and therefore may modulate the course of AP.
The complex functions of CD45 are not completely under-
stood. CD45 is an important regulating factor of B and T cell
activation and maturation [20–23]. CD45 is a member of the
PTP family known to be a major regulator of the activation
of the Src family protein tyrosine kinase (Src-PTK) in lympho-
cytes [3,24], which, in turn, is required to initiate various
immune functions including cytokine receptor mediated
signalling [2,25] and modulation of cytokine production
[26,27]. Negative and positive regulatory eﬀects on activation
of protein serine/threonine kinases such as c-Jun and p38-
MAP (mitogen-activated protein) kinases have also been
reported for CD45 in immature [28,29] and mature [3,29,30]
hematopoietic cells, respectively. Despite its relevance in the
regulation of immune cell functions its precise role remains
controversial.
Given our ﬁnding that CD45 is expressed on acinar cells
we wondered about its role in such non-hematopoietic type
cells. The involvement of protein kinase pathways has also
been reported in the immune response developed by acinar
cells. Thus, MAP kinase activation seems to be pivotal in
‘‘switching on’’ the cascade of cytokine production in acinar
cells during AP [8,31] and, on the other hand, the response
of acinar cells to cytokines is driven via the Janus kinase
(JAK) pathway [19]. Combined, these results suggest that
CD45s role on acinar cells could be to regulate protein ki-
nase activity and therefore modulate the inﬂammatory re-
sponse triggered from these particular epithelial cells within
a stressful environment.
To examine this possibility we activated acinar cells of con-
trol rats with PAAF as previously reported [7] and using dou-
ble staining measured by ﬂow cytometry CD45 expression and
TNF-Æalphaæ production. Interestingly, the distribution of aci-
nar cells on this basis revealed that negative CD45 cells showed
the greatest production of TNF-Æalphaæ, while acinar cells
showing high levels of CD45 expression were only minimally
stimulated by PAAF to produce TNF-Æalphaæ. This observa-
tion suggests that CD45 might downregulate the acinar activa-
tion. This notion is supported by data obtained in the
activation experiments carried out in vitro in which an in-
creased production of TNF-Æalphaæ together with a decreased
CD45 expression was found in acinar cells cultured in the pres-
ence of PAAF. Negative regulation of CD45 on the ‘‘inﬂam-
matory’’ response developed by acinar cells is also deduced
from in vivo studies performed in rats with AP induced by
BPDO in which a signiﬁcant decrease in the expression of
CD45 was observed at stages of AP in which acinar cells were
able to spontaneously produce TNF-Æalphaæ. This ﬁndings
concur with the results obtained in glial cells by Tan et al.
[32] who reported that CD45 cross-linking markedly attenu-
ated microglial activation. Given that in a previous study [8]
p38-MAPK phosphorylation associated with TNF-Æalphaæ
production was found in acinar cells of rats subjected to the
same model of AP, our data suggest that TNF-Æalphaæ produc-
tion could be abrogated in acinar cells as long as high levels of
CD45, with phosphatase activity, are maintained. However,
because the expression of CD45 in acinar cells becomes re-
duced in response to stressful stimuli, mitogen-activated pro-
tein kinase (MAPK) pathway might be activated and, as a
result, the inﬂammatory response developed.
Fig. 4. FACS analysis of acinar cell CD45 expression and TNF-Æalphaæ production. Dot plots show a representative example of distribution of non-
stimulated (a) and pancreatitis-associated ascitic ﬂuid (PAAF)-stimulated (b) acinar cells according to anti-CD45-PE/Cy5 and TNF-Æalphaæ-PE
labelling. Graphs represent mean values ± S.E.M. of TNF-Æalphaæ production (c) and CD45 (d) expression measured as mean ﬂuorescence intensity
(MFI, relative linear units) in non-stimulated (grey) and PAAF-stimulated (black) acinar cells. Number of experiments, 5. Paired Student t test
revealed signiﬁcant diﬀerences (P < 0.05, P < 0.01) between both conditions.
Fig. 5. CD45 mRNA expression in acinar cells of sham-operated
animals and rats with acute pancreatitis (AP) induced by bile-
pancreatic duct obstruction (BPDO) for 12 h. A representative RT-
PCR and the mean values ± S.E.M. of acinar CD45 mRNA expression
(measured as CD45/Æbetaæ-actin ratio) are shown. Number of exper-
iments, 5. Unpaired Student t test revealed signiﬁcant diﬀerences
(P < 0.05) between both experimental animal groups.
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Fig. 6. TNF-Æalphaæ production and CD45 expression in acinar cells
of rats with BPDO-induced AP measured by ﬂow cytometry. Results
are expressed as percentage of variation with respect to sham-operated
rats. Number of experiments 5. Unpaired Student t test revealed
signiﬁcant diﬀerences (P < 0.05, P < 0.01) between both experimental
animal groups.
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exclusively expressed in nucleated cells of hemetopoietic origin,
our data provides evidence that CD45 is also constitutively ex-
pressed in pancreatic acinar cells, a ﬁnding that gives new in-
sights into the mechanisms involved in the inﬂammatory
response developed by acinar cells in pancreatitis. Our data
raises the possibility that stimulation of the CD45 pathwaynegatively controls the activation of acinar cells induced by
inﬂammatory stimuli and suggest that in vivo stimulation of
CD45 may be a potential therapeutic strategy in the treatment
of AP, a disease which involves the activation of acinar cells as
initial source of cytokines.Acknowledgments: Supported by a Grant from Junta Castilla-Leo´n,
Spain (SA 123/03).Thanks are due to Mark Anderson for this linguistic
assistance.
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